Novartis Ups Bid for Chiron
Industry experts weigh in on what could be the resolution of a long saga.
Study Compares Schizophrenia Treatments
Psychiatrists offer insight on the second phase of results from a National Institutes of Health study comparing different anti-psychotic drugs.
